Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?

Expert Review of Respiratory Medicine

Volumn 7, Issue 5, 2013, Pages 451-454

  Patel, Mitesh ^a   Pilcher, Janine ^a   Beasley, Richard ^a,b  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

asthma; beclometasone; budesonide; formoterol; inhaled corticosteroid; long acting beta agonist; maintenance; reliever; SMART

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUORINATED HYDROCARBON; FORMOTEROL; LONG ACTING BETA AGONIST; LONG ACTING DRUG; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; MAJOR CLINICAL STUDY; METERED DOSE INHALER; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG COMBINATIONS; HUMANS; TREATMENT OUTCOME;

EID: 84886530641     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2013.837777     Document Type: Article

References (13)

1. O'Byrne PM, Bisgaard H, Godard PP et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am. J. Respir. Crit. Care Med. 171(2), 129-136 (2005
2. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: A randomised controlled, double-blind study. Lancet 368(9537), 744-753 (2006
3. Papi A, Corradi M, Pigeon-Francisco C et al. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: A double-blind, randomised controlled trial. Lancet Respir. Med. 1, 23-31 (2013
4. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 14(4), 902-907 (1999
5. Patel M, Pilcher J, Pritchard A et al. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: A randomised controlled trial. Lancet Respir. Med. 1, 32-42 (2013
6. Edwards SJ, Von Maltzahn R, Naya IP, Harrison T. Budesonide/formoterol for maintenance and reliever therapy of asthma: A meta analysis of randomised controlled trials. Int. J. Clin. Pract. 64(5), 619-627 (2010
7. Czarnecka K, Chapman KR. The clinical impact of single inhaler therapy in asthma. Clin. Exp. Allergy 42(7), 1006-1013 (2012
8. Sovani MP, Whale CI, Oborne J et al. Poor adherence with inhaled corticosteroids for asthma: Can using a single inhaler containing budesonide and formoterol help? Br. J. Gen. Pract. 58(546), 37-43 (2008
9. Rabe KF, Pizzichini E, Ställberg B et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-To-moderate asthma. Chest 129(2), 246-256 (2006
10. Barnes PJ. Scientific rationale for using a single inhaler for asthma control. Eur. Respir. J. 29(3), 587-595 (2007
11. Papi A, Caramori G, Adcock IM, Barnes PJ. Rescue treatment in asthma: More than as-needed bronchodilation. Chest 135(6), 1628-1633 (2009
12. Rabe KF, Adachi M, Lai CKW et al. Worldwide severity and control of asthma in children and adults: The global asthma insights and reality surveys. J. Allergy Clin. Immunol. 114(1), 40-47 (2004
13. Williams LK, Pladevall M, Xi H et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 114(6), 1288-1293 (2004